-
Survival Outcomes in People Living With HIV Who Experienced Progressive Multifocal Leukoencephalopathy Compared to the General Population
Sep 9, 2025, 16:22 PM -
Evolving Assumptions on Treatment Durability in Cost-Effectiveness Models of Cell and Gene Therapies: Insights From French HTA Submissions
Sep 9, 2025, 16:22 PM -
Differences in the Reimbursement Pathway for Ultraorphan Therapies in England and Ireland
Sep 9, 2025, 16:22 PM -
AI-Assisted Expert Computable Operation Definition (CODef) Development for Real-World Research
Sep 9, 2025, 16:22 PM -
Treatment With Semaglutide Reduces the Complication Costs Among Type 2 Diabetes Patients With CKD in China: A Short-Term Cost Analysis Based on the FLOW Trial
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 2 Diabetes Using Insulin in Sweden: A National Real-World Evidence Perspective
Sep 9, 2025, 16:22 PM -
Budgetary Impact of Ultra-Rare Diseases in Brazil: A Review of Decisions From the Past Five Years
Sep 9, 2025, 16:22 PM -
Evaluation of the Implementation Effect of Medical Service Price Reforms: A Case Study of Assisted Reproductive Services in China
Sep 9, 2025, 16:22 PM -
Digital Health Literacy, Engagement, and the Economics of Health Behavior: Evidence from the US HINTS Survey
Sep 9, 2025, 16:22 PM -
Long-Term Impact of Emicizumab in Hemophilia A (HA): Analysis by Inhibitor Status in Three Latin American (LATAM) Countries
Sep 9, 2025, 16:22 PM -
An Interactive Tool to Select Indirect Treatment Comparison Methods for Rapid Feasibility Assessment
Sep 9, 2025, 16:22 PM -
AI Assistant Meets Human: Refining Methods for Research-Tailored AI Assistants to Support Global Product Strategy, Decision Making, and HEOR Impact
Sep 9, 2025, 16:22 PM -
Applying the Delphi Method: A Scoping Review in Healthcare Decision Making and HEOR
Sep 9, 2025, 16:22 PM -
Predictive Algorithms in HTA: What Factors Influence Decision Making in NICE, SMC, and NCPE?
Sep 9, 2025, 16:22 PM -
Modeling the Anticipated Organizational Impact on Health Service Provision of the Introduction of Tirbanibulin for the Topical Treatment of Actinic Keratosis in France: EPIKA Study
Sep 9, 2025, 16:22 PM -
Opportunity Gain in Resources as New Framework to Counterpart Burnout in Healthcare Systems
Sep 9, 2025, 16:22 PM -
Evaluating the Acceptability of Vignette Studies in Eliciting Utility Values for Rare Diseases: Perspectives From European HTA Agencies
Sep 9, 2025, 16:22 PM -
English Translation, Cross-Cultural Adaptation and Validation of the French New Patient-Reported Outcome Measures of the Multiple Sclerosis Autonomy Scale (MSAS)
Sep 9, 2025, 16:22 PM -
Health Technology Assessment, Reimbursement, and Funding Landscape Challenges for Oncology Companion Diagnostics in Europe and Canada
Sep 9, 2025, 16:22 PM -
Institutional Profiles and the Likelihood of Unfavorable Submissions in Public Consultations on Breast Cancer Drugs in Brazil’s Supplementary Health System
Sep 9, 2025, 16:22 PM
